Intellectual Property Cases filed in Delaware
Cases 31 - 40 of 209
Biogen International GmbH et al v. Amneal Pharmaceuticals LLC et al. We have downloadable decisions or orders for this case
as 1:2017cv00823
Defendant: TWi Pharmaceuticals Inc., Amneal Pharmaceuticals LLC, Sawai Pharmaceutical Co., Ltd. and others
Plaintiff: Biogen International GmbH and Biogen MA Inc.
Cause Of Action: 35 U.S.C. § 271
Vanda Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc.
as 1:2020cv01104
Defendant: Teva Pharmaceuticals USA, Inc.
Plaintiff: Vanda Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 1
ACADIA Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc.
as 1:2020cv00986
Defendant: Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd.
Plaintiff: ACADIA Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Vifor Fresenius Medical Care Renal Pharma Ltd. et al v. Lupin Atlantis Holdings SA et al
as 1:2020cv00911
Defendant: Teva Pharmaceuticals USA, Inc., Lupin Pharmaceuticals, Inc., Lupin Atlantis Holdings SA and others
Plaintiff: Vifor Fresenius Medical Care Renal Pharma Ltd. and Vifor Fresenius Medical Care Renal Pharma France S.A.S.
Cause Of Action: 35 U.S.C. § 271
AstraZeneca AB et al v. Teva Pharmaceuticals USA, Inc.
as 1:2018cv01685
Defendant: Teva Pharmaceuticals USA, Inc. and Catalent Pharma Solutions, LLC
Plaintiff: AstraZeneca Pharmaceuticals LP and AstraZeneca AB
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
In re: Palbociclib Patent Litigation
as 1:2019md02912
Not Classified By Court: Aizant Drug Research Solutions Pvt. Ltd., Hetero USA Inc., Teva Pharmaceuticals USA, Inc. and others
In Re: In re: Palbociclib Patent Litigation
Cause Of Action: 35 U.S.C. § 271
In re: Auryxia (Ferric Citrate) Patent Litigation
as 1:2019md02896
Not Classified By Court: Chemo Research S.L., Insud Pharma S.L., Teva Pharmaceuticals USA, Inc. and others
Counter Defendant: Keryx Biopharmaceuticals, Inc., Panion & BF Biotech, Inc. and Chen Hsing Hsu
Counter Claimant: Lupin Atlantis Holdings SA and Lupin Ltd.
In Re: In re: Auryxia (Ferric Citrate) Patent Litigation
Cause Of Action: 35 U.S.C. § 271
Vanda Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc.
as 1:2019cv02202
Defendant: Teva Pharmaceuticals USA, Inc.
Plaintiff: Vanda Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 1
Vanda Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc.
as 1:2020cv00093
Defendant: Teva Pharmaceuticals USA, Inc.
Plaintiff: Vanda Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 1
IBSA Institut Biochimique SA et al v. Teva Pharmaceutical USA, Inc.
as 1:2019cv02115
Plaintiff: Altergon SA, IBSA Pharma Inc. and IBSA Institut Biochimique SA
Defendant: Teva Pharmaceutical USA, Inc.
Cause Of Action: 35 U.S.C. § 271

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?